WSS-25

N/A

Report date: 2024/12/03 15:16:18
NME

Base Information

Drug NameWSS-25
Drug Alias NameWSS-25
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor Of DNA Binding 1 inhibitors
TargetsInhibitor Of DNA Binding 1
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A